_version_ 1783640409184927744
collection PubMed
description
format Online
Article
Text
id pubmed-7825870
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Reed Business Information Ltd, England. Published by New Scientist Limited.
record_format MEDLINE/PubMed
spelling pubmed-78258702021-01-25 Letters New Sci Letters Reed Business Information Ltd, England. Published by New Scientist Limited. 2021-01-23 2021-01-22 /pmc/articles/PMC7825870/ /pubmed/33519009 http://dx.doi.org/10.1016/S0262-4079(21)00105-6 Text en © 2021 Reed Business Information Ltd, England Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letters
Letters
title Letters
title_full Letters
title_fullStr Letters
title_full_unstemmed Letters
title_short Letters
title_sort letters
topic Letters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825870/
https://www.ncbi.nlm.nih.gov/pubmed/33519009
http://dx.doi.org/10.1016/S0262-4079(21)00105-6